x
Filter:
Filters applied
- Regular Research Articles
- cardiovascular diseaseRemove cardiovascular disease filter
- brown adipose tissueRemove brown adipose tissue filter
- Journal of Lipid ResearchRemove Journal of Lipid Research filter
Publication Date
Please choose a date range between 2021 and 2022.
Author
- Blomberg, Niek1
- Chalhoub, Gabriel1
- Coskun, Tamer1
- Giera, Martin1
- Haemmerle, Guenter1
- Heier, Christoph1
- Kien, Benedikt1
- Kolleritsch, Stephanie1
- Kooijman, Sander1
- Kunowska, Natalia1
- Pronk, Amanda CM1
- Rensen, Patrick CN1
- Stelzl, Ulrich1
- Tambyrajah, Lauren1
- Tilp, Anna1
- van der Stelt, Mario1
- van Eenige, Robin1
- Wang, Yanan1
- Wolinski, Heimo1
- Ying, Zhixiong1
Regular Research Articles
2 Results
- Research ArticleOpen Access
Lipid droplet-mitochondria coupling via perilipin 5 augments respiratory capacity but is dispensable for FA oxidation
Journal of Lipid ResearchVol. 63Issue 3100172Published online: January 20, 2022- Benedikt Kien
- Stephanie Kolleritsch
- Natalia Kunowska
- Christoph Heier
- Gabriel Chalhoub
- Anna Tilp
- and others
Cited in Scopus: 5Disturbances in lipid homeostasis can cause mitochondrial dysfunction and lipotoxicity. Perilipin 5 (PLIN5) decorates intracellular lipid droplets (LDs) in oxidative tissues and controls triacylglycerol (TG) turnover via its interactions with adipose triglyceride lipase and the adipose triglyceride lipase coactivator, comparative gene identification-58. Furthermore, PLIN5 anchors mitochondria to the LD membrane via the outermost part of the carboxyl terminus. However, the role of this LD-mitochondria coupling (LDMC) in cellular energy catabolism is less established. - Research ArticleOpen Access
Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice
Journal of Lipid ResearchVol. 62100070Published online: March 22, 2021- Robin van Eenige
- Zhixiong Ying
- Lauren Tambyrajah
- Amanda C.M. Pronk
- Niek Blomberg
- Martin Giera
- and others
Cited in Scopus: 0Pharmacological blockade of the cannabinoid type 1 receptor, a G protein-coupled receptor expressed in the central nervous system and various peripheral tissues, reverses diet-induced obesity and dyslipidemia through the reduction of food intake and altered nutrient partitioning. This strategy is being explored for a number of therapeutic applications; however, its potency for the treatment of atherosclerotic cardiovascular disease via improvements in lipid metabolism remains unclear. Therefore, here, we aimed to investigate whether inhibition of the endocannabinoid system can attenuate atherosclerosis development through improvement of dyslipidemia.